| scholarly article | Q13442814 |
| P2093 | author name string | Kurogi Y | |
| Güner OF | |||
| P2860 | cites work | Identification of common functional configurations among molecules | Q42633535 |
| An integrated approach to three-dimensional information management with MACCS-3D. | Q43406804 | ||
| Definition of a pharmacophore for partial agonists of serotonin 5-HT3 receptors | Q77230018 | ||
| P433 | issue | 9 | |
| P921 | main subject | database | Q8513 |
| P304 | page(s) | 1035-1055 | |
| P577 | publication date | 2001-07-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Current Medicinal Chemistry | Q3007710 |
| P1476 | title | Pharmacophore modeling and three-dimensional database searching for drug design using catalyst | |
| P478 | volume | 8 |
| Q43227515 | A common feature-based 3D-pharmacophore model generation and virtual screening: identification of potential PfDHFR inhibitors |
| Q33924947 | A novel potential therapeutic avenue for autism: design, synthesis and pharmacophore generation of SSRIs with dual action |
| Q51901134 | A self-organizing algorithm for molecular alignment and pharmacophore development |
| Q97421941 | A systematic strategy for the investigation of vaccines and drugs targeting bacteria |
| Q90619451 | All in One: Cavity Detection, Druggability Estimate, Cavity-Based Pharmacophore Perception, and Virtual Screening |
| Q30845402 | Alzheimer's therapeutics: neurotrophin small molecule mimetics |
| Q30875193 | Benchmarking methods and data sets for ligand enrichment assessment in virtual screening |
| Q30650320 | Boosting Virtual Screening Enrichments with Data Fusion: Coalescing Hits from Two-Dimensional Fingerprints, Shape, and Docking |
| Q56916101 | Chapter 9 Molecular Similarity: Advances in Methods, Applications and Validations in Virtual Screening and QSAR |
| Q44341489 | Chemical function-based pharmacophore generation of selective kappa-opioid receptor agonists by catalyst and phase |
| Q59050007 | Combined 3D QSAR Based Virtual Screening and Molecular Docking Study of Some Selected PDK-1 Kinase Inhibitors |
| Q51410824 | Combining molecular dynamics simulation and ligand-receptor contacts analysis as a new approach for pharmacophore modeling: beta-secretase 1 and check point kinase 1 as case studies |
| Q54485705 | Computational Insights into Ligand Selectivity of Estrogen Receptors from Pharmacophore Modeling. |
| Q26997089 | Computational methods in drug discovery |
| Q38819860 | Computer-aided discovery of new FGFR-1 inhibitors followed by in vitro validation. |
| Q37198661 | Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction |
| Q54573815 | Design and synthesis of novel dual-action compounds targeting the adenosine A(2A) receptor and adenosine transporter for neuroprotection |
| Q34175087 | Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors |
| Q35595863 | Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels |
| Q57712447 | Discovery of CNS-Like D3R-Selective Antagonists Using 3D Pharmacophore Guided Virtual Screening |
| Q39920314 | Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening. |
| Q90650682 | Discovery of Novel Glucagon Receptor Antagonists Using Combined Pharmacophore Modeling and Docking |
| Q51557447 | Discovery of new antifungal leads via pharmacophore modeling and QSAR analysis of fungal N-myristoyl transferase inhibitors followed by in silico screening. |
| Q39445530 | Discovery of new heat shock protein 90 inhibitors using virtual co-crystallized pharmacophore generation |
| Q51667857 | Discovery of new β-D-galactosidase inhibitors via pharmacophore modeling and QSAR analysis followed by in silico screening. |
| Q51695973 | Discovery of new β-D-glucosidase inhibitors via pharmacophore modeling and QSAR analysis followed by in silico screening. |
| Q47600381 | Discovery of novel potent nuclear factor kappa-B inhibitors (IKK-β) via extensive ligand-based modeling and virtual screening |
| Q50728831 | Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis. |
| Q37296002 | Docking, virtual high throughput screening and in silico fragment-based drug design |
| Q30576720 | Effects of multiple conformers per compound upon 3-D similarity search and bioassay data analysis |
| Q50744649 | Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors |
| Q50985589 | Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors |
| Q51070891 | Ensemble pharmacophore meets ensemble docking: a novel screening strategy for the identification of RIPK1 inhibitors |
| Q46609728 | Generation and validation of the first predictive pharmacophore model for cyclin-dependent kinase 9 inhibitors |
| Q34266641 | Generation of Predictive Pharmacophore Models for CCR5 Antagonists: Study with Piperidine- and Piperazine-Based Compounds as a New Class of HIV-1 Entry Inhibitors |
| Q34209301 | Hierarchical virtual screening: identification of potential high-affinity and selective β(3)-adrenergic receptor agonists. |
| Q42028513 | Homology modeling and structural analysis of human P-glycoprotein |
| Q28485115 | Identification of novel HIV 1--protease inhibitors: application of ligand and structure based pharmacophore mapping and virtual screening |
| Q41035643 | Identification of novel inhibitors for Pim-1 kinase using pharmacophore modeling based on a novel method for selecting pharmacophore generation subsets. |
| Q39314390 | Identification of potential CCR5 inhibitors through pharmacophore-based virtual screening, molecular dynamics simulation and binding free energy analysis |
| Q30341584 | Impact of scoring functions on enrichment in docking-based virtual screening: an application study on renin inhibitors. |
| Q57471866 | In search of the representative pharmacophore hypotheses of the enzymatic proteome of Plasmodium falciparum: a multicomplex-based approach |
| Q35097744 | In silico identification and evaluation of leads for the simultaneous inhibition of protease and helicase activities of HCV NS3/4A protease using complex based pharmacophore mapping and virtual screening |
| Q35995265 | In silico pharmacology for drug discovery: applications to targets and beyond |
| Q87370170 | Informing Mechanistic Toxicology with Computational Molecular Models |
| Q83444808 | Insight into analysis of interactions of GW9508 to wild-type and H86F and H137F GPR40: A combined QM/MM study and pharmacophore modeling |
| Q84078786 | Insights from ligand and structure based methods in virtual screening of selective Ni-peptide deformylase inhibitors |
| Q51666820 | Integration-mediated prediction enrichment of quantitative model for Hsp90 inhibitors as anti-cancer agents: 3D-QSAR study |
| Q37778775 | Ligand Macromolecule Interactions: Theoretical Principles of Molecular Recognition |
| Q34006732 | Ligand-receptor interaction between triterpenoids and the 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) enzyme predicts their toxic effects against tumorigenic r/m HM-SFME-1 cells |
| Q34993147 | Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease |
| Q35476224 | Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling |
| Q54426552 | Minimum requirements of hydrophobic and hydrophilic features in cationic peptide antibiotics (CPAs): pharmacophore generation and validation with cationic steroid antibiotics (CSAs). |
| Q84342604 | Molecular docking and structural analysis of cofactor-protein interaction between NAD⁺ and 11β-hydroxysteroid dehydrogenase type 2 |
| Q43532099 | Molecular modeling study on chemically diverse series of cyclooxygenase-2 selective inhibitors: generation of predictive pharmacophore model using catalyst |
| Q39739852 | Mouse 11β-hydroxysteroid dehydrogenase type 2 for human application: homology modeling, structural analysis and ligand-receptor interaction. |
| Q39559444 | Novel Method for Pharmacophore Analysis by Examining the Joint Pharmacophore Space |
| Q37399793 | Novel approach for efficient pharmacophore-based virtual screening: method and applications |
| Q39531618 | Novel virtual lead identification in the discovery of hematopoietic cell kinase (HCK) inhibitors: application of 3D QSAR and molecular dynamics simulation. |
| Q36749332 | PharmaGist: a webserver for ligand-based pharmacophore detection |
| Q43831895 | Pharmacophore Mapping of a Series of 2,4-Diamino-5-deazapteridine Inhibitors of Mycobacterium avium Complex Dihydrofolate Reductase |
| Q43145376 | Pharmacophore mapping of arylamino-substituted benzo[b]thiophenes as free radical scavengers |
| Q36358068 | Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1). |
| Q34621241 | Pharmacophore modelling: applications in drug discovery |
| Q37788606 | Pharmacophore-Based Virtual Screening |
| Q35709484 | Pharmacophore-based discovery of a novel cytosolic phospholipase A(2)α inhibitor |
| Q33556394 | Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets |
| Q28481547 | Prediction of promiscuous p-glycoprotein inhibition using a novel machine learning scheme |
| Q92444290 | Promising Terpenes as Natural Antagonists of Cancer: An In-Silico Approach |
| Q34288171 | Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach. |
| Q39964651 | Relationships between molecular structure and perceived odor quality of ligands for a human olfactory receptor |
| Q55093753 | Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds |
| Q35229529 | Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor |
| Q38655350 | Simulated annealing molecular dynamics and ligand-receptor contacts analysis for pharmacophore modeling |
| Q33243843 | Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death. |
| Q39437066 | Stereoselective synthesis and QSAR study of cytotoxic 2-(4-oxo-thiazolidin-2-ylidene)-2-cyano-N-arylacetamides |
| Q57004233 | Structure-Based Classification of Antibacterial Activity |
| Q46882026 | Synthesis and three-dimensional qualitative structure selectivity relationship of 3,5-disubstituted-2,4-thiazolidinedione derivatives as COX2 inhibitors |
| Q51759061 | The discovery of a novel and selective inhibitor of PTP1B over TCPTP: 3D QSAR pharmacophore modeling, virtual screening, synthesis, and biological evaluation |
| Q34564278 | The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies. |
| Q33247681 | Virtual ligand screening: strategies, perspectives and limitations |
| Q28261293 | Virtual screening for the discovery of bioactive natural products |
| Q33712915 | iDrug: a web-accessible and interactive drug discovery and design platform |
Search more.